A new batch of neflamapimod capsules led to increased plasma drug concentrations and demonstrated improvement (p<0.001 vs. old capsules; ...

Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

Hospice use varies depending on whether a person has Parkinson’s disease, Lewy body dementia or Alzheimer’s disease and those with Parkinson’s may have more unmet needs, a new study finds.

Implementation of patient and public involvement and engagement (PPIE) to enable patients and carers to feel included and equal to healthcare professionals is challenging to do well. Here, leaders ...

An increased risk of cognitive decline and Alzheimer's disease dementia has been identified in subjects with olfactory ...

This article originally appeared in Research Colorado.Research at the University of Denver is showing promise for the ...

14, 2025 — There may be a link between hearing impairment and an increased risk of developing Parkinson's according to new ... have recreated the growth of Lewy bodies in human neurons and ...

IGC Pharma (IGC) announced an advancement in its Artificial Intelligence platform with the development of a new AI-driven model designed to ...

A form of Parkinson's disease caused by mutations in a gene known as PINK1 has long been labeled rare. But our research shows ...

Lewy bodies Intra-cytoplasmic (neurons) α-synuclein Parkinson's disease Lewy bodies Intra-cytoplasmic (neurons) α-synuclein Complex I and IV deficiency Huntington's disease Neuronal intra ...